Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 168.50
Bid: 167.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.796%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 168.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First day of dealings

4 Sep 2007 07:00

Hampden Underwriting Plc 04 September 2007 4 September 2007 Hampden Underwriting plc First Day of Dealings on AIM Hampden Underwriting plc ('Hampden Underwriting' or the 'Company'), which has been incorporated primarily to provide a limited liability direct investment into the Lloyd's insurance market through its subsidiary underwriting vehicle, Hampden Corporate Member Limited ('HCM'), today announces that it has raised an initial £5.2 million (before expenses) at a price of £1.00 per ordinary share through an offer for subscription to the public in the UK ('the Offer'). Application has been made for the Admission to AIM of 5,238,566 ordinary shares of the Company. It is expected that Admission in relation to these ordinary shares issued to date will become effective and dealings on AIM will commence at 8.00am today under the ticker symbol 'HUW'. The Offer will remain open until 28 September 2007. Of the total gross proceeds of the Offer to date, £5.1 million was subscribed in cash and £0.1 million in shares in Heritage Underwriting Agency plc. The net cash proceeds from this initial fund raising will be used to acquire underwriting participations in Lloyd's syndicates and invest in other Lloyd's related opportunities. HCM will bid in the capacity auctions on 4 and 5 September 2007, 13 and 14 September 2007 and 25 and 26 September 2007. Smith & Williamson is acting as the Nominated Adviser, Broker and Promoter to the Company. Sir Michael Oliver, Chairman of Hampden Underwriting, said: 'We are delighted with investor demand and are very pleased to be joining AIM. We do not believe that any other company provides the same level of concentrated exposure to Lloyd's underwriting and this is a key distinction. As we believe that there is significant further demand amongst UK investors, the Offer has been extended.' Enquiries: Hampden Underwriting Jeremy Evans 020 7863 6567 Smith & Williamson Corporate Finance Azhic Basirov 020 7131 4000 Limited David Jones Joanne du Plessis Cardew Group Tim Robertson 020 7930 0777 Shan Shan Willenbrock David Roach For copies of the prospectus please contact: Tax Efficient Solutions Smith & Williamson Investment Management Limited 020 7131 4502 tes@smith.williamson.co.uk About Hampden Underwriting • Hampden Underwriting's subsidiary, HCM, will be advised by Hampden Agencies Limited ('HAL'). HAL is the largest provider of third party capital to the Lloyd's market, with over £2 billion of capacity under management in 2007 which, the directors of Hampden Underwriting (the 'Directors') believe, gives it an influential voice in the Lloyd's market as a whole. • The Directors believe that Hampden Underwriting will offer the only opportunity currently available for investment in a quoted company whose principal purpose is to participate in a spread portfolio of Lloyd's syndicates rather than manage syndicates itself. There are other companies whose shares are traded on the London Stock Exchange and whose activities include underwriting at Lloyd's, but the Directors believe that these do not provide such concentrated exposure to Lloyd's underwriting as the Company. • The Company's strategy is to seek to generate returns for its shareholders primarily through: • the acquisition of underwriting participations in Lloyd's syndicates and providing the necessary supporting funds at Lloyd's. • the acquisition of corporate members of Lloyd's as suitable opportunities arise; and • the acquisition in other Lloyd's insurance-related investments and products, if and when suitable opportunities arise. • Hampden Underwriting will seek to benefit from the positive market conditions created in the wake of the recent US catastrophes. In summary: • The Directors believe that the main reason why recent results have been so much better than might have been expected from past experience is that Lloyd's has undertaken a comprehensive process of internal reform over the past few years, the most crucial component of which was the establishment of the Franchise Performance Directive in 2002. For the calendar year 2005 Lloyd's reported a loss of £103 million, in spite of the fact that it was trading in a year when there were some US$83 billion of major catastrophe losses. 2006 saw a low catastrophe incidence, which resulted in a reported calendar year profit of £3.7 billion, which again compares favourably with Lloyd's peers. • The Directors believe that two of the main ramifications of the large US catastrophe losses of 2004 and 2005 are that: (i) they have led to an improvement of rating levels for certain classes of business; and (ii) they have changed the shape of the worldwide insurance industry. The Directors believe that this gives the best Lloyd's syndicates a significant trading opportunity for the medium term. • Rates have increased by substantial margins in classes of insurance business such as reinsurance, US property and US offshore energy following these losses. The Directors believe that what is arguably more important, however, is that there has been an erosion of worldwide competition in some insurance classes, especially certain sectors of the reinsurance market. • The Directors do not expect to see a significant softening of rates in many of the major catastrophe exposed insurance classes in the medium term and believe that current underwriting conditions offer the capability to produce good underwriting profits (though not indefinitely). HAL Through HCM, Hampden Underwriting will not invest in the Lloyd's market as a whole, but in a carefully chosen spread portfolio of syndicates that will be recommended by HCM's Lloyd's adviser, HAL. HAL's advice will be based upon analysis of the past and forecasted performance of syndicates to grade their potential to outperform the market through any given cycle. The table below shows the way in which members advised by HAL have outperformed relative to the Lloyd's market as a whole since 2001: Percentage return on capital invested HAL-advised Lloyd's members market Year of account 2001 (31.1)% (45.9)% 2002 34.3% 28.6% 2003 52.9% 47.0% 2004 26.2% 25.9% 2005 (estimate) (0.5)% (12.2)% 2006 (estimate) 39.8% 36.3% Past performance should not be seen as an indication of future performance. Sources: HAL 2001 to 2004 at 36 months, calculated from Synopsis MAIR reports. Lloyd's Market 2001 to 2004 at 36 months from Lloyd's Global Results/ Year end QMRs. 2005 estimates calculated from 2007 Q1 QMR returns. Lloyd's 2006 estimate based on Lloyd's aggregate of the 2006 Q4 QMRs. HAL 2006 estimate based on a combination of Syndicate official estimates (accounting for 64% of HAL capacity) and Hampden Underwriting Research Syndicate estimates for remaining 36%. Funds at Lloyd's are assumed at 40%. All returns include personal expenses but are before members' agent's charges. The Directors believe that another potential benefit for the Company is that HAL has built up strategic relationships with some of the underwriters in the market and this leaves it well placed to introduce HCM to early investments in new syndicates and other underwriting opportunities within the Lloyd's market. Directors Sir James Michael Yorrick Oliver, aged 67, (Non-executive Chairman) Sir Michael Oliver is a director of a number of investment funds, and the chairman of a specialised Central and Eastern European fund. He was previously a director, Investment Funds at Hill Samuel Asset Management and of Scottish Widows Investment Partnership Limited. He was a partner in stockbrokers Kitkat & Aitken for 20 years and subsequently managing director of Carr Kitkat & Aitken between 1990 and 1993. He is non-executive chairman of Zirax plc and Europa Oil & Gas (Holdings) plc, both of which are quoted on AIM. John Andrew Leslie, aged 62, (Non-executive Director) Andrew Leslie has 40 years' experience as an insurance broker. He started his career with Leslie & Godwin in 1967, where he held a number of senior positions, until he left to join Morgan Read and Coleman as a director. In 1991 he and three others effected a management buy out of the company which was then purchased by Arthur J. Gallagher (UK) Limited in 1996. Until recently he was a main board director of Arthur J. Gallagher (UK) Limited. Jeremy Richard Holt Evans, aged 49, (Non-executive Director) Jeremy Evans joined Minories Underwriting Agencies in 1993, which was subsequently transferred to Aberdeen Underwriting Advisers Limited, with specific responsibility for its corporate capital plans, including the development of a conversion scheme for existing members. He has been a director of HAL since 1999 and is also the managing director of Nomina plc. Harold Michael Clunie Cunningham, aged 59, (Non-executive Director) Michael Cunningham joined Neilson Hornby Crichton & Co in 1976, becoming a partner in 1981. In 1986, he became a director of Neilson Cobbold Limited, formerly Neilson Milnes Limited, which is now part of Rathbone Brothers. He has worked in the investment management business for over 20 years and formerly had responsibility for venture capital trusts and Rathbones Enterprise Investment Scheme portfolios and Inheritance Tax service, which have raised over £100 million in total. Hampden Agencies Limited Nigel Hanbury, Chief Executive Nigel Hanbury joined Lloyd's in 1979 as an external member and became a Lloyd's broker in 1982. He later moved to the Members' Agency side. He serves on the board of the Association of Lloyd's Members and was elected to the Council of Lloyd's for 'Working Names' constituency and served on that body between 1999 and 2001, as well as participating on the Market Board and other Lloyd's committees. In January 2005, Nigel was re-elected to the Council for his second three year term. Nick Carrick, Hampden Underwriting Research Nick Carrick joined Lloyd's in 1977 and moved into an underwriting agency role in 1983. He is a Fellow of the Chartered Insurance Institute and was appointed head of Hampden Underwriting Research in 2002. Jeremy Evans, Director Jeremy Evans, also a director of Hampden Underwriting, as detailed above, is an executive director of HAL where he has particular responsibility for business development. This document has been approved as a financial promotion under the Financial Services and Markets Act 2000 by Smith & Williamson Corporate Finance Limited ('S&W'), which is authorised and regulated by the Financial Services Authority. S&W is acting for Hampden Underwriting plc and no-one else and will not be responsible to anyone other than Hampden Underwriting plc for providing the protections afforded to customers of S&W. This document is for information only and does not form part of any offer or invitation to subscribe for shares. This document is not a prospectus, but an advertisement, and investors should not subscribe for the shares referred to in this document except on the basis of the prospectus dated 13 August 2007 which is available from: Tax Efficient Solutions, Smith & Williamson Investment Management Limited, 25 Moorgate, London, EC2R 6AY (tel: +44(0)20 7131 4502; email: tes@smith.williamson.co.uk). This document should not be distributed directly or indirectly, to any persons with addresses in the United States of America (or any of its territories or possessions), Canada, Japan, Australia or the Republic of South Africa, or to any corporation, partnership or other entity created or organised under the laws thereof, or in any other country outside the United Kingdom where such distribution may lead to a breach of any legal or regulatory requirement. The shares referred herein have not been and will not be registered under the United States Securities Act 1933 (as amended) or under any of the applicable securities laws of Canada, Japan, Australia or the Republic of South Africa and may not, subject to certain exceptions, be offered for sale or sold or subscribed directly or indirectly within the United States, Canada, Japan, Australia or the Republic of South Africa or to or by any national, resident or citizen of any such countries. This document does not represent advice about subscribing for, purchasing or selling shares and is not a substitute for independent professional advice about legal, investment or tax matters. It is only intended to provide some basic information. If you are in any doubt as to the action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other qualified financial adviser authorised under the Financial Services and Markets Act 2000. Please note that neither Hampden Underwriting nor S&W is permitted to provide you with legal, investment or tax advice. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.